Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

Similar articles for PubMed (Select 23139965)

1.

The prognostic value of the P53 protein and the Ki67 marker in breast cancer patients.

Golmohammadi R, Pejhan A.

J Pak Med Assoc. 2012 Sep;62(9):871-5.

PMID:
23139965
2.
3.

Phosphohistone H3 outperforms Ki67 as a marker of outcome for breast cancer patients.

Gerring Z, Pearson JF, Morrin HR, Robinson BA, Harris GC, Walker LC.

Histopathology. 2015 Feb 24. doi: 10.1111/his.12678. [Epub ahead of print]

PMID:
25728258
4.

Predictive Role of p53 Protein as a Single Marker or Associated with ki67 Antigen in Oral Leukoplakia: A Retrospective Longitudinal Study.

Gissi DB, Gabusi A, Servidio D, Cervellati F, Montebugnoli L.

Open Dent J. 2015 Jan 30;9:41-5. doi: 10.2174/1874210601509010041. eCollection 2015.

5.

Does smoking affect the Ki67 and p53 expressions in asymptomatic fully impacted lower third molar follicles?

Toptaş O, Baykul T, Başak K.

J Oral Maxillofac Surg. 2015 May;73(5):819-26. doi: 10.1016/j.joms.2014.10.015. Epub 2014 Oct 22.

PMID:
25544297
6.

Breast cancer statistics and markers.

Donepudi MS, Kondapalli K, Amos SJ, Venkanteshan P.

J Cancer Res Ther. 2014 Jul-Sep;10(3):506-11. doi: 10.4103/0973-1482.137927. Review.

7.

A novel model for Ki67 assessment in breast cancer.

Romero Q, Bendahl PO, Fernö M, Grabau D, Borgquist S.

Diagn Pathol. 2014 Jun 16;9:118. doi: 10.1186/1746-1596-9-118.

8.

Expression of p53, Ki67, EcPV2- and EcPV3 DNA, and viral genes in relation to metastasis and outcome in equine penile and preputial squamous cell carcinoma.

van den Top JG, Harkema L, Lange C, Ensink JM, van de Lest CH, Barneveld A, van Weeren PR, Gröne A, Martens A.

Equine Vet J. 2015 Mar;47(2):188-95. doi: 10.1111/evj.12245. Epub 2014 May 4.

PMID:
24898479
9.

Multi-level gene expression signatures, but not binary, outperform Ki67 for the long term prognostication of breast cancer patients.

Tobin NP, Lindström LS, Carlson JW, Bjöhle J, Bergh J, Wennmalm K.

Mol Oncol. 2014 May;8(3):741-52. doi: 10.1016/j.molonc.2014.02.007. Epub 2014 Feb 28. Erratum in: Mol Oncol. 2014 Sep 12;8(6):1159.

PMID:
24630985
10.

Reply to Ki67 in breast cancer: a useful prognostic marker!

Denkert C, von Minckwitz G.

Ann Oncol. 2014 Feb;25(2):542-3. doi: 10.1093/annonc/mdt564. Epub 2014 Jan 15. No abstract available.

11.

Ki67 in breast cancer: a useful prognostic marker?

Caldarella A, Crocetti E, Paci E.

Ann Oncol. 2014 Feb;25(2):542. doi: 10.1093/annonc/mdt561. Epub 2014 Jan 10. No abstract available.

12.

The potential utility of geminin as a predictive biomarker in breast cancer.

Sundara Rajan S, Hanby AM, Horgan K, Thygesen HH, Speirs V.

Breast Cancer Res Treat. 2014 Jan;143(1):91-8. doi: 10.1007/s10549-013-2786-5. Epub 2013 Dec 1.

PMID:
24292956
13.

[Prognostic significance of p53 expression in patients with mammary gland cancer].

Shchurov NF, Pogorelaia TIu, Zaplatina SV.

Klin Khir. 2013 Jul;(7):36-8. Russian.

PMID:
24283043
14.

Genomic instability: a stronger prognostic marker than proliferation for early stage luminal breast carcinomas.

Vincent-Salomon A, Benhamo V, Gravier E, Rigaill G, Gruel N, Robin S, de Rycke Y, Mariani O, Pierron G, Gentien D, Reyal F, Cottu P, Fourquet A, Rouzier R, Sastre-Garau X, Delattre O.

PLoS One. 2013 Oct 15;8(10):e76496. doi: 10.1371/journal.pone.0076496. eCollection 2013.

15.

The relationship between multiple clinicopathological features and nerve invasion in pancreatic cancer.

Wang PH, Song N, Shi LB, Zhang QH, Chen ZY.

Hepatobiliary Pancreat Dis Int. 2013 Oct;12(5):546-51.

16.

Relationship of TP53 and Ki67 expression in bladder cancer under WHO 2004 classification.

Wang L, Feng C, Ding G, Zhou Z, Jiang H, Wu Z.

J BUON. 2013 Apr-Jun;18(2):420-4.

PMID:
23818355
17.

Ki67 and proliferation in breast cancer.

Pathmanathan N, Balleine RL.

J Clin Pathol. 2013 Jun;66(6):512-6. doi: 10.1136/jclinpath-2012-201085. Epub 2013 Feb 22. Review.

PMID:
23436927
18.

A simple immunohistochemical panel comprising 2 conventional markers, Ki67 and p53, is a powerful tool for predicting patient outcome in luminal-type breast cancer.

Kobayashi T, Iwaya K, Moriya T, Yamasaki T, Tsuda H, Yamamoto J, Matsubara O.

BMC Clin Pathol. 2013 Feb 6;13:5. doi: 10.1186/1472-6890-13-5.

19.

New insight into Ki67 expression at the invasive front in breast cancer.

Gong P, Wang Y, Liu G, Zhang J, Wang Z.

PLoS One. 2013;8(1):e54912. doi: 10.1371/journal.pone.0054912. Epub 2013 Jan 31.

20.

Correlation between Ki67 and breast cancer prognosis.

Kontzoglou K, Palla V, Karaolanis G, Karaiskos I, Alexiou I, Pateras I, Konstantoudakis K, Stamatakos M.

Oncology. 2013;84(4):219-25. doi: 10.1159/000346475. Epub 2013 Jan 24. Review.

PMID:
23364275
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk